Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced participation of its executive management team in a fireside chat at the 2021 Bloom Burton & Co. Healthcare Investor Conference on April 20, 2021, at 2:30 p.m. ET. Interested individuals can access the live audio webcast through the 'News/Events' section on Aurinia's corporate website. A replay will also be available. Aurinia focuses on therapies for serious diseases, having launched LUPKYNIS™ (voclosporin), the first FDA-approved oral treatment for active lupus nephritis in adults.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in a fireside chat during the 2021 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 20, 2021 at 2:30 p.m. ET.

In order to participate in the audio webcast, interested parties can access the live webcast under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.

ABOUT AURINIA

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company has introduced LUPKYNIS™ (voclosporin), the first FDA-approved oral therapy dedicated for the treatment of adult patients with active lupus nephritis (LN). The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210415005158/en/

FAQ

What is the date and time of Aurinia's fireside chat during the 2021 Bloom Burton & Co. Conference?

Aurinia's fireside chat is scheduled for April 20, 2021, at 2:30 p.m. ET.

How can I access the live webcast for Aurinia's conference participation?

The live webcast can be accessed under 'News/Events' in the 'Investors' section of Aurinia's website.

What product has Aurinia Pharmaceuticals launched for lupus nephritis?

Aurinia has launched LUPKYNIS™ (voclosporin), the first FDA-approved oral therapy for active lupus nephritis.

Where is Aurinia Pharmaceuticals headquartered?

Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia.

Is there a replay available for the fireside chat?

Yes, a replay of the webcast will be available on Aurinia's website.